GridX Connects U.S. Biotech Investors with Latin America's Untapped Innovation Potential BUENOS AIRES—(BUSINESS WIRE)—GridX, Latin America's leading biotechnology investment fund and company builder, is embarking on an international roadshow that will showcase 21 innovative startups across three major U.S. cities. The tour, which kicks off this week in Tulsa on April 23, will then travel to New York on April 29, and conclude in San Francisco on May 5. The roadshow aims to connect Latin America's most promising biotech ventures with U.S. capital markets, highlighting the region's exceptional biodiversity and burgeoning talent pool. "Latin America represents an untapped frontier in biotechnology, with unique competitive advantages," said Matias Peire, CEO and co-founder of GridX. "Our goal is to bridge these innovative startups with global investors, enabling them to grow while offering early access to groundbreaking technologies." The roadshow boasts support from industry leaders such as Amazon Web Services, Tulsa-based Atento Capital, and SynBioBeta. Notable speakers include John Cumbers, founder of SynBioBeta, and Po Bronson, managing director of Indie Bio, the world's leading biotech accelerator. The 21 startups featured in the roadshow span four strategic verticals: Human Health, Agri-food and Land Use, Bio-industry, and Deep Biotech. Each company leverages Latin America's scientific talent and biological resources to develop cutting-edge solutions. Despite the current slower venture capital environment, biotechnology startups are garnering significant attention for their potential to revolutionize healthcare, especially in obesity treatment and genetic disease management. Advancements in artificial intelligence are further accelerating this innovation. Latin America's R&D ecosystem is home to over one million highly qualified researchers and technicians, primarily based in academic institutions. This rich pool of talent enables the formation of world-class entrepreneurial teams at competitive costs. Additionally, the region's natural resources, particularly from Amazon basin countries, which contain approximately 10% of the world's known biodiversity, offer exceptional genetic resources for innovative research and development. GridX has cultivated an impressive portfolio of 81 biotechnology startups, with founding teams from seven countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Uruguay. This portfolio represents the most diverse biotechnology startup community in Latin America. For more information about GridX and the upcoming roadshow, visit gridexponential.com.